In the ARIC study, which included 9851 Americans over a median follow-up of17.4 years, both galectin-3 and CRP were found to be associated with PADincidence, emphasizing the role of fibrosis and inflammation in PAD development[13]. The gene discussed is LGALS3; the disease is peripheral arterial disease.